Inventor
AAY NAING
US19 patents
⚠️ This page may combine multiple inventors who share the name “AAY NAING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REVOLUTION MEDICINES INC
10 patentsUS10590090B2Mar 17, 2020
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC28 citations92
US11690915B2Jul 4, 2023
Ras inhibitors
REVOLUTION MEDICINES INC9 citations82
US11168102B1Nov 9, 2021
Bicyclic heteroaryl compounds and uses thereof
REVOLUTION MEDICINES INC5 citations70
US11673896B2Jun 13, 2023
Pyridine compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC1 citations61
US12565476B2Mar 3, 2026
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US11702411B2Jul 18, 2023
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US11661401B2May 30, 2023
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US12365688B2Jul 22, 2025
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations59
US12258366B2Mar 25, 2025
Bicyclic heteroaryl compounds and uses thereof
REVOLUTION MEDICINES INC0 citations59
US11739093B2Aug 29, 2023
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC1 citations59
EXELIXIS INC
5 patentsUS7803839B2Sep 28, 2010
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC46 citations95
US7915250B2Mar 29, 2011
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC22 citations91
US8362002B2Jan 29, 2013
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC12 citations83
US11597699B2Mar 7, 2023
MEK inhibitors and methods of their use
EXELIXIS INC0 citations61
US8012956B2Sep 6, 2011
Tropane compounds
EXELIXIS INC1 citations50